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IFN-c Upregulates Expression of the Mouse
Complement C1rA Gene in Keratinocytes via
IFN-Regulatory Factor-1
Sung June Byun1, Ik-Soo Jeon1, Hyangkyu Lee2 and Tae-Yoon Kim2
We examined the expression of the mouse complement component C1rA (mC1rA) in IFN-g-stimulated mouse
keratinocytes (Pam 212) and found that it was upregulated. To analyze the mechanism involved, we cloned the
2,150 bp 50-flanking region of mC1rA by the vectorette-PCR technique, and identified the transcription start site
of mC1rA by rapid amplification of complementary DNA ends. Analysis of the 50 sequence revealed putative
binding sites for activator protein 1, CCAAT/enhancer binding protein (C/EBP), signal transducer and activator of
transcription 1 (STAT-1), IFN-regulatory factor-1 (IRF-1), and others. We detected transcriptional activation
dependent on this upstream region in reporter gene assays and Northern blots. To identify the cis-acting
regulatory elements involved, we analyzed serial deletion constructs of the promoter using luciferase reporters.
The 80 to 19 bp region, which contains a putative IRF-1 binding site, was required for both basal promoter
activity and responses to IFN-g. The use of site-directed point mutations, electrophoresis mobility shift assays,
and supershift assays indicated that the putative IRF-1 binding site was essential for both IFN-g-dependent and -
independent transcriptional activity of the mC1rA promoter. We conclude that IFN-g stimulates mC1rA gene
expression via IRF-1 in mouse keratinocytes.
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INTRODUCTION
The cytokines of the IFN family consist of two subfamilies:
type I (IFN-a, -b, and -o) and type II (IFN-g). IFN-g has a wide
range of immunological effects that enhance pathogen
detection, inhibit viral growth and cell proliferation, and
facilitate recruitment of effector cells to sites of infection
(Boehm et al., 1997; Der et al., 1998; Ehrt et al., 2001). Its
expression is restricted to certain cells of the immune system;
indeed it is mainly secreted by T cells and natural killer cells
when they are activated by antigens and mitogens (Yssel
et al., 1994; Trinchieri, 1995). In contrast to this expression
pattern, the IFN-g receptor is expressed on the majority of cell
types (Batch et al., 1995; Sakatume and Finbloom, 1996) and
the biological effects of IFN-g are mediated through the well-
known JAK-signal transducer and activator of transcription
(STAT) and IFN-regulatory factor-1 (IRF-1) pathway (Schind-
ler and Darnell Jr, 1995; Bach et al., 1997; Stark et al.,1998).
The most crucial activity of IRF-1 is its ability to activate
transcription from specific promoters (Pine, 1992; Matsuya-
ma et al., 1993; Kimura et al., 1994). It has been extensively
characterized at the molecular level, and plays a major role
in host defense against pathogens, the prevention of tumors,
and the development of the immune system. It is a critical
factor in IFN-g-mediated signaling, and in the development
and the function of natural killer, natural killer T, and
cytotoxic T lymphocyte cells (Duncan et al., 1996; Ogasa-
wara et al., 1998; Ohteki et al., 1998).
The complement system, which consists of proinflamma-
tory proteins circulating in the peripheral blood and tissue
fluids, is a phylogenetically ancient host defense system. It is
designed to identify targets for phagocytosis, to stimulate
inflammation, and to kill invading bacteria and viruses
directly (Cooper, 1985; Schumaker et al., 1987; Schmidt
and Colten, 2000). The complement system consists of three
cascades: the classical and alternative pathways, and the
lectin pathway (Collard et al., 2000). The complement
component C1r is the first component of the classical pathway
and is expressed mainly in liver (Colten, 1976). The first
enzymatic event in the cascade of the classical pathway is the
activation of component C1, a multimolecular complex
consisting of two loosely interacting entities: C1q, the
recognition subunit, and C1r2-C1s2, the catalytic one. C1r
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is responsible for intrinsic C1 activation, a two-step process
involving autolytic activation of C1r followed by C1r-
mediated cleavage of the proenzyme C1r. C1 is activated
upon binding antigen–antibody complexes containing IgM or
IgG (Boes et al., 1998).
The mouse C1r gene was duplicated during evolution and
the resulting mouse complement component C1rA (mC1rA)
and B genes display different tissue expression patterns with
mC1rA primarily expressed in the liver and mC1rB restricted
to the male reproductive system (Garnier et al., 2003). We
previously cloned a mouse C1r cDNA assigned to mC1rA and
showed that expression of mC1rA is upregulated in allo-
grafted skin (Byun et al., 2001). Allogeneic response is known
to trigger abundant production of IFN-g, most or all of which
is presumably derived from specifically stimulated T-cell
clones whose receptors are engaged by antigen (Benson
et al., 1985; Halloran et al., 1992). Although IFN-g induces
the expression of the human C1r (hnC1r) gene in normal
human skeletal myoblasts, and other complement compo-
nents in various tissues (Lappin et al., 1992; Legoedec et al.,
1997; Terui et al., 2000), the mechanisms involved remain
unclear.
In the present work, we show that expression of mC1rA
and hnC1r is upregulated by IFN-g in mouse and human
keratinocytes, respectively. We have cloned the 50-flanking
region of the mC1rA gene for the first time. Characterization
of the promoter region of the mC1rA gene shows that a
putative IRF-1 binding site in the promoter plays a pivotal role
in basal transcription and IFN-g-mediated stimulation of
transcription.
RESULTS
IFN-c induces mC1rA expression
It is well known that IFN-g expression is induced by
allogeneic responses. RT-PCR analysis showed that IFN-g
messenger RNA (mRNA) is dramatically increased on the day
8 allografted skins but the other grafted skins did not show
any upregulations (Figure S1). We previously reported the
cloning of the mC1rA cDNA, and upregulation of mC1rA
expression in allografted mouse skin (Byun et al., 2001).
Here, in order to examine the effect of IFN-g on mC1rA
expression in mouse keratinocytes, we performed time- and
dose-dependent studies for identification of optimal condi-
tion using real-time PCR analysis (Figure S2a and b). The data
showed that stimulation of Pam 212 with 200 U/ml of
IFN-g led to a time-dependent increase in mC1rA mRNA
which peaked 24 hours after IFN-g application and continued
to 48 hours (Figure S2a). For dose-dependent study, we
incubated Pam 212 with different IFN-g concentrations
for 24 hours (Figure S2b). The incubation period of 24 hours
was used, because there was maximum mC1rA mRNA
induction. The mC1rA mRNA levels increased with increas-
ing IFN-g doses until 200 U/ml of IFN-g treatment. These
experiments demonstrate that IFN-g induce mC1rA mRNA
not only in a time but also in a concentration-dependent
manner.
To further explore the effect of IFN-g on mC1rA and hnC1r
expression in mouse hepatocytes and human keratinocytes,
respectively, we performed following studies. As shown in
Figure 1, Northern blot analyses showed that IFN-g drama-
tically increased the expression of hnC1r and mC1rA mRNA
3 or 6 hours after treatment of human keratinocytes and
mouse hepatocytes, respectively. The elevated mRNA levels
persisted for at least 24 hours in both cell lines. Although the
induction fold of hnC1r mRNA was lower than that of
mC1rA, upregulation patterns of hnC1r and mC1rA mRNA
transcription in mouse and human keratinocytes were very
similar (Figure 1a and b) but mouse hepatocytes showed
relatively delayed and lower induction pattern, compared
with in mouse keratinocytes (Figure 1c). These data suggest
that human keratinocytes and mouse hepatocytes may harbor
specific signal-transduction pathways mediated by IFN-g or
this study was not optimally performed for maximum
stimulations in both cells. We have therefore used Pam 212
cells as a model cell line to study the mechanism of induction
of mC1rA expression by IFN-g.
The upregulation patterns of mC1rA mRNA transcription
in Pam 212 cells treated with 200 U/ml of IFN-g were very
similar in both real-time PCR and Northern blot analyses
(Figure S2a and Figure 1a) but the relative induction fold was
slightly low in the real-time PCR analysis suggesting that two
methods have a different sensitivity.
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Figure 1. Effect of IFN-c on C1r mRNA expression in keratinocytes and
hepatocytes. (a) Pam 212, (b) HaCaT, and (c) Hepa-1c1c7 cells were
stimulated for the indicated times with 200 U of IFN-g. Total RNA was
prepared at the indicated times and Northern blot analysis was performed as
described in Materials and Methods using 30mg of total RNA for each lane.
The same blot was stripped and re-probed for GAPDH expression to
normalize RNA loading and transfer. The relative intensities of observed
bands were analyzed by densitometry and expressed relative to intensity
value for mC1rA/GAPDH mRNA level. As a control, relative intensity value of
mC1rA/GAPDH mRNA in non-treated cells is set as 1.
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IFN-c increases mC1rA transcription
To see whether the elevated level of mC1rA mRNA in
response to IFN-g results from increased transcription of
mC1rA or increased stability of its mRNA, we treated Pam
212 cells with 10mg/ml of actinomycin D. Figure 2 is
showing that it blocked IFN-g-mediated induction of mC1rA,
indicating that the mRNA level change is dependant of
nucleic acid synthesis supporting transcriptional regulation in
mouse keratinocytes.
Cloning of the 50-flanking region of the mC1rA gene
To examine the mechanism of upregulation of mC1rA
transcription at the gene level, we cloned its 50-flanking
region including its promoter using vectorette PCR (Figure
S3a). Four independent amplified PCR products were cloned
and sequenced from the DraI, HpaI, PvuII, and HindIII
vectorette libraries, respectively. The HpaI vectorette library
produced about 2.2 kb of PCR product containing the
upstream region of the mC1rA gene. The PCR product was
named clone 2271 because of the length of the DNA
fragment. The sequence of the 2271 clone was deposited in
GenBank databases (accession no. AF444142). Although the
negative control HindIII vectorette library yielded amplified
DNA fragments, they contained nonspecific sequences,
implying improper adapter ligation or improper PCR ampli-
fication (Figure S3a).
We determined the transcription start site of the
mC1rA gene using 50-rapid amplification of cDNA ends
PCR. The PCR amplification using the set of adapters
and the mC1rA inner primer produced approximately
150 bp PCR fragments, whose 50-end sequence revealed the
location of the transcription start site (Figure S3b). The
amplified DNA fragments were cloned and sequenced.
The sequence indicated that the starting point was located
121 bp upstream of the 30-end of the mC1rA inner primer,
and is indicated by þ1 in Figure 3a. This result showed
that the major transcription start point was located
12 bp upstream of the reported mC1rA cDNA (Byun et al.,
2001).
Expression of the mC1rA gene is mediated by a putative
IRF-1 binding element within the 50-flanking region of the
mC1rA promoter – Clone 2271 was sequenced to identify
putative transcription factor binding sites using the TRANS-
FAC program (Wingender et al., 2000). The analysis revealed
no canonical TATA-box, suggesting that the gene was a
housekeeping one (Azizkhan et al., 1993; Collins and
Bornstein, 1996; Gongora et al., 2000). On the other hand,
several putative transcription factor binding sites, including
ones for activator protein 1, STAT-1, CCAAT/enhancer
binding protein (C/EBP), and IRF-1 were identified in the
promoter region (data not shown). This result is in agreement
with a previous report (Garnier et al., 2003). To identify the
cis-acting regulatory elements involved in mC1rA basal
promoter activity, a series of 50-end deletion mutants was
made by successive deletion of the promoter region. These
deletion constructs were transfected into Pam 212 cells and
pGL3-Basic was included as a negative control. As shown in
Figure 6b, basal transcription from all the 50-deletions from
2150 to 80 appeared normal, but further deletion to
position 19 resulted in a decrease of basal transcription
activity of nearly 80%, and additional deletion to position
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Figure 2. IFN-c treatment does not affect mC1rA mRNA stability. Pam 212
cells were incubated with 200 U of IFN-g for 2 hours before addition of
10mg/ml actinomycin D. The cells were treated with actinomycin D
for the indicated times. The mC1rA mRNA was detected by Northern blot
analysis as described above. The relative intensities of observed bands
were expressed relative to intensity value for mC1rA/GAPDH mRNA level.
As a control, relative intensity value of mC1rA/GAPDH mRNA at the
0 hour is set as 1.
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Figure 3. Deletional analysis of the mC1rA promoter. (a) Nucleotide
sequence of the 50-flanking region of the mC1rA gene. Bold letters indicate
the known cDNA sequence of the mC1rA gene. The underlined bold letters
indicate the sequence of the mC1rA inner primer used to identify the
transcription start site of mC1rA and the vectorette PCR. The symbol þ1
refers to the transcription initiation site. The putative-binding sites for
transcription factors are indicated by underlining and italics (C/EBP) or boxed
letters (IRF-1 or STAT-1). The residues substituted in STAT-1/C/EBP and IRF-1/
C/EBP are indicated by italic capital letters. The start point of each deletion
construct is indicated by an arrow and number. (b) Schematic representation
of the mC1rA deletion constructs and relative promoter activities. A series of
50-deletions were generated by PCR. Pam 212 cells were transfected with 3 mg
of the indicated deletion mutants and 0.5 mg of phRL-TK, and relative
luciferase activities were measured 24 hours after the start of transfection. The
data are means7SD of relative transcription activities in three independent
experiments yielding similar results.
www.jidonline.org 1189
SJ Byun et al.
mC1rA Upregulation by IFN-g
þ 12 had almost the same effect. These results indicate that
the critical elements for mC1rA basal transcription are
located between position 80 and position 19. This region
contains putative binding sites for IRF-1 and STAT-1, both of
which are known to be implicated in the IFN-g signaling
pathway, as well as a binding site for C/EBP. Surprisingly, the
putative binding sites for IRF-1 and STAT-1 both overlapped
with the C/EBP binding motif (Figure 3a). To identify which
residues are required for basal promoter activity, we
constructed site-directed mutants of 483/þ121/pGL3-Basic
using the primer set described in Materials and Methods. We
introduced the 8-bp substitution into the residues overlapping
the STAT-1/C/EBP (TTCCCCAA-GACTAGTC) and IRF-1/C/
EBP (TTTCAAAA-GACTAGTC) binding motifs. This sub-
stituted sequence (GACTAGTC) corresponds to the mutant C/
EBP gel shift oligonucleotide (Santa Cruz Biotechnology,
Santa Cruz, CA). Luciferase reporter assays showed that the
IRF-1/C/EBP mutant had dramatically decreased basal pro-
moter activity whereas the STAT-1/C/EBP mutant had only
slightly decreased activity (Figure 4a). As the promoter
activities of the wild type and STAT-1/C/EBP or IRF-1/CEBP
mutant constructs in NIH/3T3 cells were similar to those in
Pam 212 cells, we concluded that the DNA sequences of the
IRF-1/C/EBP motif was critical for basal transcriptional of
mC1rA (Figure 4a). To further characterize the IRF-1/C/EBP
sequence, we constructed IRF-1 and C/EBP point mutants
(Figure 4b). The IRF-1 mutant construct had decreased
transcriptional activity whereas the C/EBP mutant did not
(Figure 4b) indicating that the putative IRF-1 binding site was
essential for basal transcription of mC1rA in mouse kerati-
nocytes. We designated the putative IRF-1 binding site, IRF-E.
From the above result, we postulated that IFN-g enhanced
mC1rA gene expression via IRF-E. As expected, the effect of
IFN-g on mC1rA expression was dramatically decreased with
the 18/þ 121/Luc mutant, which has the upstream region of
the promoter deleted. Moreover, IFN-g treatment of Pam 212
cells harboring a construct containing a point mutation in the
IRF-E did not result in any stimulation of transcription
(Figure 5). These findings indicate that the sequence from
position 80 to position 19 and, in particular, the IRF-E
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Figure 4. Identification of important regulatory elements in the 50-flanking region of mC1rA by site-directed mutagenesis. (a) Schematic representation of the
substitution constructs. The wild-type construct (483/þ121/Luc) served as template. The substituted 8 bp sequence is indicated by the open box. Three
micrograms of the wild-type or mutant constructs was co-transfected with 0.5mg of phRL-TK plasmid into either Pam 212 or NIH/3T3 cells. Control cultures
were transfected with empty vector and phRL-TK. After 24 hours, the cells were harvested for luciferase reporter assays. Data shown are means7SD of three
independent experiments with triplicate samples in each experiment. (b) Schematic representation of the point mutation constructs. The IRF-1/C/EBP binding site
of the mC1rA promoter is indicated by the boxed letters, and capital letters represent the point-mutated residues in the IRF-1 and C/EBP binding motifs. Three
micrograms of the indicated mutant or wild-type construct was transiently transfected into Pam 212 cells with 0.5 mg of phRL-TK plasmid, and luciferase activity
was measured as described above.
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Figure 5. IRF-E is essential for transcription of mC1rA. (a) Schematic
representation of the mutant constructs for mC1rA promoter analysis. The
putative IRF-1 binding site in the mC1rA promoter region is indicated by
an open (mutant) or closed (wild type) box. (b) Luciferase activities of cells
transfected with deletion or point mutants of the mC1rA promoter. Pam 212
cells were transiently transfected with 3 mg of the indicated constructs and
0.5mg of phRL-TK, cultured in the presence or absence of IFN-g for 24 hours,
and assayed for luciferase. The data are means7SD of relative transcription
activities in three independent experiments yielding similar results.
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within this region, plays a critical role in both basal
transcription of mC1rA and the enhancing activity of IFN-g
in mouse keratinocytes.
Role of IRF-1 in mC1rA gene expression in mouse keratinocytes
The transcription factors IRF-1 and -2 are known to bind to
the IRF-E motif (Taniguchi et al., 2001). To see if IFN-g could
affect the expression of IRF-1 or -2 protein, Pam 212 cells
were stimulated with 200 U/ml of IFN-g and harvested at the
indicated times for Western blot analysis. As shown in Figure
6a, IFN-g increased expression of IRF-1 protein and the
pattern of upregulation was similar to that of mC1rA mRNA,
although the increase in IRF-1 protein was much less,
suggesting that IRF-1 protein might be only one of the
mediators of the IFN-g stimulus. However IFN-g did not affect
the induction of the IRF-2 protein expression in mouse
keratinocytes.
To identify transcription factors that interact with the
IRF-E of the mC1rA promoter, we performed an electrophor-
esis mobility shift assay by using nuclear extracts of primary
mouse keratinocytes treated with IFN-g and an oligonucleo-
tide probe encompassing the IRF-E. Because the sequences
of the IRF-E showed the overlapped binding motifs for IRF-1
and C/EBP (Figure 3a), we used consensus C/EBP and
IRF-1 gel shift oligonucleotides (Santa Cruz Biotechnology)
for competition assay. As shown in Figure 6b, addition
of a 100-fold molar excess of an unlabeled consensus IRF-1
oligonucleotide (Santa Cruz Biotechnology) or of cold IRF-E
probe completely inhibited formation of the protein–DNA
complex but a 100-fold molar excess of unlabeled consensus
C/EBP gel shift oligonucleotide (Santa Cruz Biotechnology)
did not completely inhibition. This result indicates that
the bound protein is a transcription factor of the IRF
family. To further characterize this factor, we performed
supershift assays with anti-IRF-1, -IRF-2, and -IFN consensus
sequence binding protein antibodies. Figure 6b shows that
only antibody specific for IRF-1 retarded the protein–DNA
complex.
In order to demonstrate that IRF-1 can stimulate mC1rA
expression, we performed luciferase reporter assays. As
expected, luciferase expression from the wild-type 483/
þ 121/Luc construct was dramatically increased in Pam 212
cells harboring an IRF-1 expression vector but not in cells
harboring the IRF-E mutant construct (Figure 7a). Finally, to
determine whether IRF-E confers IRF-1-inducibility on the
thymidine kinase (TK) promoter in vivo, we made a luciferase
reporter construct containing three copies of w-IRF-E (or m-
IRF-E) fused to a truncated TK promoter. The mini-TK/Luc, the
w-IRF-E/mini-TK/Luc, or the m-IRF-E/mini-TK/Luc constructs
were then co-transfected into Pam 212 cells with IRF-1/
pcDNA3 and the cells were incubated for 24 hours. As shown
in Figure 7b, IRF-1 protein clearly stimulated the transcrip-
tional activity of the w-IRF-E/mini-TK/Luc plasmid compared
with that of the mini-TK/Luc. In contrast, no induction could
be detected in transfection with the construct containing the
mutant IRF-E motif. This stimulatory activity of IRF-1 on the
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Figure 6. Requirement for IRF-1 for activation of the mC1rA promoter by IFN-c. (a) IFN-g induces IRF-1 protein expression in mouse keratinocytes.
Western blot analysis of whole-cell lysates of Pam 212 cells treated for the indicated times with 200 U/ml of IFN-g was performed using antibodies recognizing
IRF-1 or IRF-2, as indicated on the left. The same blot was then re-probed with an antibody against Rb. The relative intensities of observed bands were
expressed relative to intensity value for IRF-1 or -2/Rb protein level. As a control, relative intensity value of IRF-1 or -2/Rb protein level at the 0 hour is set
as 1, respectively. (b) Nuclear extracts (5 mg) from mouse primary cells stimulated with IFN-g for 24 hours was subjected to competition or supershift assays using
an oligonucleotide corresponding to the IRF-E sequence (27 to 8) of the mC1rA promoter. Competition assays were performed with a 100-fold molar excess
of unlabeled IRF-E, consensus IRF-1 (Santa Cruz Biotechnology), or consensus C/EBP oligonucleotides (Santa Cruz Biotechnology). Supershift assay was
performed by preincubating the reaction mixtures with 4 mg of antibody against the indicated protein. Supershifted (arrowhead) and specific protein–DNA
(arrow) complexes are indicated. F, free probe.
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IRF-E containing promoter was correlated with IFN-g
stimulation in mouse keratinocytes.
DISCUSSION
The complement component C1r is a modular serine protease
responsible for autolytic activation of C1, the macromole-
cular complex that triggers the classical complement path-
way. The complement system not only plays a key role in
host defense systems but also orientates and stimulates the
subsequent adaptive immune response (Fearon and Locksley,
1996; Hoffmann et al., 1999). Paradoxically, its inappropriate
activation may contribute to various pathological states, such
as Alzheimer’s disease and prion diseases (Rogers et al.,
1992; Klein et al., 2001; Mabbott et al., 2001). Molecular
cloning and biochemical dissection of the many components
of the complement pathway over the last two decades has led
to a detailed understanding of the mechanism of complement
activation as a host defense system (Carroll, 2004). None-
theless, only a few studies have pointed to the involvement of
IFN-g in C1r expression (Lappin et al., 1992; Legoedec et al.,
1997; Terui et al., 2000).
Previously, we cloned a gene encoding a complement C1r
component from grafted mouse skin. Both autografted and
allografted skin tissues were associated with the strong
inflammatory process, and mC1r expression was significantly
upregulated in the grafted skin tissues on day 1 post-
transplantation, suggesting that the complement system reacts
in the early response to the skin graft procedure (Byun et al.,
2001). Upregulation of mC1rA expression in the allografted
mouse skins is mediated by IFN-g signal pathway but
induction of mC1rA mRNA in the autografted ones is
transduced by other factors (Figure S1). In this study, we
characterized a mechanism of the mC1rA upregulation by
IFN-g stimulation at the molecular level in mouse keratino-
cytes and showed that the mouse keratinocytes responded to
IFN-g with a higher transcription rate than did the hepato-
cytes, suggesting that the hepatocytes have a slightly different
IFN-g signaling pathway or set of transcription factors
involved in IFN-g-mediated signaling. We assume that a
similar result might occur in human keratinocytes and
hepatocytes; however, this was not further examined in this
study.
As the promoter region of the mC1rA gene was not cloned
yet, we cloned the 50-flanking region of the mC1rA mRNA and
characterized both the transcription start site and the essential
elements for basal transcription (Figures 3 and 4). Although the
transcription initiation point of mC1rA mRNA was located
3 bp downstream of the previously reported site (Garnier et al.,
2003). This is not surprising, as heterogeneous transcription
initiation is known to occur in other TATA-less promoters of
housekeeping and IFN-regulated genes (Azizkhan et al., 1993;
Collins and Bornstein, 1996; Gongora et al., 2000). We also
showed that IFN-g upregulates mC1rA expression via putative
IFN-g response elements located within the mC1rA promoter
region. However, the fold induction from a luciferase construct
using clone 2271 was a little lower than the result obtained by
Northern blot analysis, suggesting that the upstream region of
clone 2271 contains additional IFN-g-positive mC1rA regula-
tory elements.
Successive 50-end deletion and site-directed mutagenesis
of clone 2271 of the mC1rA promoter showed that the IRF-1
binding site (IRF-E) is critical for both IFN-g-dependent and -
independent mC1rA gene expression (Figure 5). However, we
cannot be sure that only IRF-1 proteins bound to the IRF-E of
the mC1rA promoter in response to IFN- g. IRF-1 and -2 can
bind directly to IRF-1 binding sites (Taniguchi et al., 2001)
and the DNA-binding activity of IFN consensus sequence
binding protein per se is very weak but is dramatically
increased by interaction with IRF-1 or IRF-2 (Bovolenta et al.,
1994; Sharf et al., 1997). In addition, IFN consensus
sequence binding protein expression was also induced by
treatment of Pam 212 cells with IFN-g (data not shown).
Although IRF-2 may be involved in a negative feedback
mechanism limiting post-induction of IRF-1 activity (Harada
et al., 1994) and IFN-g did not induce IRF-2 expression
(Figure 6a), IRF-2 may have bound to the IRF-E as it can bind
to IRF-1 binding sites. Indeed, in the light of the previous
reports (Bovolenta et al., 1994; Sharf et al., 1997; Taniguchi
et al., 2001), the proteins bound to the mC1rA IRF-E may be a
combination of IRF-1, IRF-2, and IFN consensus sequence
binding protein. Importantly, we were able to demonstrate
binding of IRF-1 proteins to the IRF-E (Figure 6b) and transient
transfection experiments with the wild-type and mutated IRF-
E/mini-TK/Luc constructs, demonstrated that a co-transfected
IRF-1 expression vector activated luciferase expression
through the IRF-E (Figure 7), further confirming the role of
the IRF-E/IRF-1 system in regulating mC1rA expression in
mouse keratinocytes.
m-IRF-E
w-IRF-E
pGL3-basic
–483/+121/Luc
–483/+121/Luc
IRF-1 (+)
IRF-1 (–)
IRF-1 (+)
IRF-1 (–)
0 50
0 20 40 60
100 150
Relative luciferase activity
Relative luciferase activity
mini-TK/Luc
mini-TK/Luc
mini-TK/Luc
a
b
Figure 7. IRF-1 activates the mC1rA promoter through the IRF-E. (a) Pam
212 cells were co-transfected with 0.5 mg of IRF-1/pcDNA, 0.2 mg of phRL-TK,
and 3 mg of the wild-type 483/þ121/Luc construct or the corresponding
mutant vector. As a negative control, pGL3 empty vector was transfected. The
cells were harvested 24 hour post-transfection and assayed for luciferase.
(b) The mini-TK/Luc, w-IRF-E/mini-TK/Luc, or m-IRF-E/mini-TK/Luc constructs
(1 mg) were co-transfected into Pam 212 cells with IRF-1/pcDNA3 (0.5 mg).
The cells were maintained for 24 hours in culture before measuring luciferase
activities. The data are means7SD of relative transcription activities in three
independent experiments yielding similar results.
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Why would the complement system be crucial to the
biology of epidermis? The skin is the first line of defense of the
body against pathogenic non-self and consequently controls
many different aspects of immune responses. Keratinocytes
express various immune response proteins, such as proin-
flammatory cytokines, chemokines, and antimicrobial pep-
tides. Skin tissue fluids contain a battery of humoral immune
response factors, including Igs, complement components,
lysozyme, coagulation, and growth factors. Although, their
concentrations are usually measured low compared to those
in plasma, their local concentrations in the body could be
high enough to illicit appropriate responses (Olszewski,
2005).
Our previous (Byun et al., 2001) and present studies
indicate that the skin also responds to tissue graft by
producing a complement protein through the IFN-g signaling
pathway. The complement system is also known to be
involved in skin allograft rejection, which is mediated by
antigen-presenting cells, such as Langerhans cell and dermal
dendritic cells. Failure in the regulation of the complement
system leads to autoimmune diseases and hypersensitive
reactions (Brand et al., 1994). Therefore, C1r expression
appears to be an important immunoregulatory factor both in
pathogen invasion and the skin graft.
In summary, our findings suggest that IFN-g-induced
increase in the mC1rA gene expression required de novo
protein synthesis and it was found that IRF-1 was induced by
IFN-g. Mutation and deletion analyses indicated that the IRF-
E site is responsible for the cytokine-mediated increase in
gene expression in Pam 212 cells. Although the supershift
and the transfection of the IRF-1 expression plasmid showed
that the mC1rA induction by IFN-g is solely owing to IRF-1
but we cannot completely rule out a contribution from other
IRF-E binding proteins, because we detected IFN-g-inducible
IRF-E binding proteins other than IRF-1 in electrophoresis
mobility shift assays (data not shown). Further identification
and characterization on the roles of these proteins in the
regulation of mC1rA is required.
Up to now little has been known about the regulation of
mC1rA expression at the molecular level. In this study, we
have established the molecular basis and elucidated the
operational details of the regulation of mC1rA gene
transcription by IRF-1. In view of its importance as a host
defense system, further elucidation of the relationship
between the complement system and IFN-g is desirable.
MATERIALS AND METHODS
Reagents
Recombinant human and mouse IFN-g were purchased from R&D
systems (Minneapolis, MN). [a-32P]dCTP (3,000 mCi/mmol) and
[g-32P]ATP (3,000 mCi/mmol) were from Amersham Biosciences
(Piscataway, NJ). All other chemicals were from Sigma-Aldrich (St
Louis, MO).
Skin graft
Mouse skin was grafted according to a described method (Byun
et al., 2001). Mice were housed and maintained in an animal facility
at the institute, Catholic Research Institute of Medical Science.
Animal protocols used for this study were approved by College of
Medicine, The Catholic Univeristy of Korea. The autografted and
allografted skins were obtained at days 1 and 8 after skin
transplantation for total RNA extraction.
Semiquantitative RT-PCR
Total RNA was isolated from the auto and allografted skins as well as
BALB/C skins with Trizol reagent (Gibco-BRL, Rockville, MD). The
cDNA was prepared from 2mg of total RNA using an ImProm-IITM
Reverse transcription system (Promega, Madison, WI) according to
the manufacturer’s instructions. cDNA (1ml) was used for each PCR
reaction of 50 ml in volume using TaKaRa Ex Taq (TaKaRa, Otsu,
Shiga, Japan). The following primers were used for PCR amplifica-
tion: mouse IFN-g sense primer, 50-TGCATCTTGGCTTTG
CAGCTCTTC-30; antisense primer, 50-GGGTTGTTGACCTC
AAACTTGGCA-30; mouse glyceraldehyde-3-phosphate dehydrogen-
ase (GAPDH) sense primer, 50-AACTTTGGCATTGTGGAAG
GGCTC-30; antisense primer, 50-ACCCTGTTGCTGTAGCCGTATT
CA-30. Each cycle of PCR amplification consisted of denaturation at
941C for 45 seconds, annealing at 601C for 45 seconds, and
extension at 721C for 30 seconds. 30 cycles were performed for
IFN-g and 21 cycles for GAPDH. PCR products were resolved on
1.2% agarose gels. The amplification of GAPDH was used to
normalize cDNA loading into each lane.
Cell culture
Pam 212 (a mouse keratinocyte cell line, provided by Dr Stuart
Yuspa, National Cancer Institute, Bethesda, MD), HaCaT (human
keratinocytes, obtained from Professor N. Fusenig, German Cancer
Research, Germany), Hepa-1c1c7 (a mouse liver cell line, pur-
chased from ATCC, Rockville, MD), and NIH/3T3 were cultured in
DMEM (Gibco-BRL) supplemented with 10% fetal bovine serum
(Gibco-BRL) and 100 U/ml penicillin/streptomycin (Gibco-BRL) at
371C in an incubator containing 5% CO2. For experiments, cells
were grown to 70% confluence and starved with serum-free DMEM
for 12 hours; they were then washed with phosphate-buffered saline
and stimulated with 200 U/ml of IFN-g for the indicated time periods
until harvested.
Primary cell culture
The primary mouse keratinocytes and conditioned media were
purchased from the Yale Skin Diseases Research Core Center (Yale
University School of Medicine, New Haven, CT). The culture was
maintained in the conditioned medium that was changed every 3
days. The cells grown to 70–80% confluence were stimulated with
the conditioned medium containing 200 U/ml of IFN-g for 24 hours
and harvested for extractions of nuclear proteins.
Northern blot analysis
The cell cultures were harvested at the indicated times after IFN-g
stimulation. RNA was extracted with Trizol reagent (Gibco-BRL)
according to the manufacturer’s protocol. The total RNA (30mg) was
electrophoresed on 1.0% agarose gels containing formaldehyde,
transferred to a nylon filter (Nytran plus, Schleicher & Schuell,
Dassel, Germany) and hybridized with [32P]-labeled mC1rA or
hnC1r cDNA probes. A mouse or human GAPDH cDNA was used in
control hybridizations to normalize differences in loading and
transfer of RNA samples. After autoradiography, quantitation of the
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signals was performed by densitometry analysis with Gel Doc 2000
gel documentation systems (Bio-Rad Lab, Hercules, CA).
Real-time PCR
Pam 212 cells were treated with 200 U/ml of IFN-g for the indicated
times. The cells were also stimulated with different doses of IFN-g (0,
50, 100, 200, 400, or 800 U/ml) for 24 hours to obtain a dose-
dependent curve. Total RNA was isolated from the treated cells using
Trizol reagent (Gibco-BRL), followed by DNase I (TaKaRa) treatment
to eliminate genomic contamination. First-strand cDNA was
prepared from 1mg of total RNA using an ImProm-IITM Reverse
transcription system (Promega). Real-time PCR was performed with
1ml of cDNA and mC1rA primers (sense, 50-CACAGCCCAAGG
CATTTGGAAGAA-30; antisense, 50-TCTGATGATGCGCTCCTTCTG
TGT-30) using the LightCycler FastStart DNA Master SYBR Green I kit
(Roche, Mannheim, Germany) following the manufacturer’s instruc-
tions under following conditions: denaturation at 951C for 10 sec-
onds, annealing at 581C for 5 seconds, and extension at 721C for
6 seconds. Forty-five-cycle real-time PCR was performed using a
LightCycler Instrument (Roche). The data from each PCR run were
analyzed using LightCycler software 4.0 (Roche). The final data were
normalized to GAPDH and are presented as relative fold inductions.
The following GAPDH primers were used: sense, 50-AACCTGC
CAAGTATGATGAC-30; antisense, 50-ATACCAGGAAATGAGCTT
GA-30. Quantitation was performed using at least three separated
total RNA samples for each treatment group.
mRNA stability
To assess whether IFN-g alters the stability of mC1rA mRNA or its
transcriptional activity, Pam 212 cells were incubated with IFN-g for
2 hours and 10 mg/ml actinomycin D (Sigma) was added. Total RNA
was isolated at various times thereafter and subjected to Northern
blot and quantitation analysis as described above.
Cloning of the 50-flanking region of the mC1rA gene
The 50-flanking region of the mC1rA gene was cloned by the
vectorette PCR method (Wiemann et al., 1996). The following
oligonucleotides were used: V1, 50-CAAGGAGAGGACGCTGT
CTGTCGAAGGTAAGGAACGGACGAGAGAAGGGAGAGT-30; V2,
50-CTCTCCCTTCTCGAATCGTAACCGTTCGTACGAGAATCGCTGT
CCTCTCCTTG-30; universal vectorette primer, 50-CGAATCGTAACC
GTTCGTACGAGAATCGCT-30; mC1rA inner primer, 50-GTAAGTT
GAAGGAGGGAGTAGGCATACAGG-30; and mC1rA outer primer,
50-CTCCATAGAGCTTCTGAGGGAGGTAAATGG-30. Oligonucleo-
tides V1 and V2 constituted the blunt vectorette adapter. Before
annealing the oligonucleotides, V1 was phosphorylated at its 50-end
with T4 polynucleotide kinase (Invitrogen, Carlsbad, CA). Genomic
DNA was isolated from C57BL/6 mouse liver tissue using standard
procedures (Hofstetter et al., 1997), and the integrity of the DNA was
monitored by agarose gel electrophoresis. The genomic DNA (9 mg)
was digested with DraI, EcoRV, HpaI, or PvuII following the
supplier’s (Roche) recommendations. As negative controls, the
genomic DNA was digested with HindIII or EcoRI. The digested
DNA was purified by extraction with an equal volume of phenol and
chloroform, and precipitated with ethanol. The vectorette adapters
(30 pmol) were ligated with the digested DNA for 16 hours at 161C in
a volume of 30 ml using 40 U of T4 DNA ligase (New England
Biolabs, Beverly, MA). The ligase was then heat-inactivated at 701C
for 15 minutes. Six vectorette libraries were prepared. A first-round
PCR amplification was carried out in a 50 ml reaction mixture
containing 1 Ex-Taq PCR buffer (TaKaRa), 2.5 U TaKaRa Ex Taq
(TaKaRa), 200mM dNTPs, the vectorette universal primer (200 nM),
and the mC1rA outer primer (200 nM). The PCR mixture was
prepared before addition of 1ml of the vectorette adapter ligation
mix. The template DNA was pre-denatured for 1 minute at 941C,
denatured at 981C for 20 seconds, annealed, extended to primers for
15 minutes at 681C, and elongated for 20 minutes at 721C. Thirty
cycles were carried out using a GeneAmp PCR System 2400
(Applied biosystems, Foster City, CA). For the second round hemi-
nested PCR, 1 ml of the first-round PCR amplification product was
used as template under identical PCR conditions. The PCR products
were analyzed on a 1% agarose gel, cloned into pGEM-T-Easy
vector (Promega), and sequenced by the dideoxynucleotide chain-
termination method with an ABI automated DNA sequencer.
5-Rapid amplification of cDNA ends PCR
To identify the transcription start point of mC1rA, we used a
SMARTTM rapid amplification of cDNA ends cDNA Amplification Kit
(BD Bioscience Clontech, Palo Alto, CA). Total RNA was extracted
from Pam 212 cells and used for cDNA synthesis. First-strand cDNA
was synthesized using the 50-CDS and SMART II A oligo (BD
Bioscience Clontech). PCR amplification was performed using the
gene-specific primer (mC1rA inner primer) and the universal primer
mix, and the PCR amplification products were subcloned into
pGEM-T-Easy vector (Promega). Twelve clones were selected and
sequenced to confirm the transcription initiation site.
Preparation of plasmid constructs
The vectorette PCR amplification product, in which the promoter
region of the mC1rA is flanked by HindIII and SalI sites, was cloned
into the HindIII and XholI sites of pGL3-Basic (Promega) and used as
template to generate all further constructs. The progressive 50-
deletion constructs 2,150/þ 121/, 483/þ 121/, 155/þ 121/,
80/þ 121/, 18/þ 121/, and þ 12/þ 121/pGL3-Basic were made
by the PCR method. The point mutant versions of 483/þ 121/
pGL3-Basic were prepared by QuickChange site-directed mutagen-
esis kit (Stratagene, LaJolla, CA). The STAT-1/C/EBP oligonucleotide
primers were 50-TCCCATCGCCTCAGCCAGACTAGTCATGGAC
CACCAGATGGC-30 and its complementary antisense oligonucleo-
tide (TTCCCCAATMGACTAGTC). The IRF-1/C/EBP oligonucleotide
primers were 50-CCAGCAAGCAACGAGGAGACTAGTCCCAAAAC
TAAACTGGGAA-30 and its complementary antisense oligonucleo-
tide (TTTCAAAA-GACTAGTC). The C/EBP oligonucleotide primers
were 50-CCAGCAAGCAACGAGGAGATCAAAACCAAAACTAAAC-30
and its complementary antisense oligonucleotide (TT-GA). The
IRF-1 oligonucleotide primers were 50-CGAGGATTTCAAAACCAG
GACTAAACTGGGAACTCA-30 and its complementary antisense
oligonucleotide (AA-GG). Mutated residues are underlined. These
constructs were transformed into cells and the inserts were verified
by sequencing. The mini-TK/luciferase construct (mini-TK/Luc) was
generated by subcloning the TK promoter region from pMLuc-2
(Novagen, San Diego, CA) into pGL3-Basic (Promega). The reporter
constructs designated as w-IRF-E/mini-TK/Luc (wild type) and m-IRF-
E/mini-TK/Luc (mutant) were generated by cloning three copies of
the double-stranded oligonucleotide corresponding to the 27 to 8
site of the mC1rA promoter region as direct repeats into the upstream
1194 Journal of Investigative Dermatology (2007), Volume 127
SJ Byun et al.
mC1rA Upregulation by IFN-g
region of mini-TK/Luc. The DNA sequences of the oligonucleotides
were as follows: wild-type IRF element, 50-TCAAAACCAAAAC
TAAACTG-30; mutant type IRF element, 50-TCAAAACCAGGAC
TAAACTG-30. The mutated sites are underlined and all constructs
were verified by DNA sequencing. The IRF-1 expression vector was
prepared by subcloning the PCR-amplified open-reading frame of
mouse IRF-1 cDNA into pcDNA3 (Invitrogen), and verified by
sequencing.
Transient transfection and luciferase assay
Transient transfections were performed using Lipofectin (Invitrogen).
Briefly, 5 105 cells were seeded per 60-mm culture plate the day
before transfection and grown to about 70% confluence. Three
micrograms of plasmid DNA prepared with a Qiagen kit (Qiagen,
Santa Clara, CA) was used for transfection in each 60-mm plate.
Transfection was allowed to proceed for 12 hours. The transfected
cells were washed with 4 ml of phosphate-buffered saline and
stimulated with 200 U/ml of IFN-g or 0.5mg of mouse IRF-1 expression
vector. After stimulation, the cells were maintained in the stimulation
medium for the indicated times. Transfection efficiencies were
adjusted by co-transfection of 0.5mg of phRL-TK vector (Promega).
After the experimental treatments, cells were washed twice with cold
phosphate-buffered saline, lysed in the passive lysis buffer provided
with the dual luciferase kit (Promega), and assayed for luciferase
activity using a TD-20/20 luminometer (Turner Designs, Sunnyvale,
CA). All transfections were performed in triplicate, and data are
presented as ratios of Firefly to Renilla luciferase activities.
Western blotting
To prepare whole-cell lysates, cells were harvested, resuspended in
lysis buffer (20 mM Tris-Cl (pH 7.5), 1 mM EDTA, 1 mM EGTA, 150 mM
NaCl, 1% Triton X-100, 1 mM dithiothreitol, and protease inhibitor
mixture) and centrifuged at 14,000 r.p.m. at 41C for 10 minutes. The
protein concentration in the supernatant was determined with the
bicinchoninic acid protein assay (Pierce, Rockford, IL). Thirty
micrograms of protein was resolved on a 9% SDS-PAGE and
transferred to a nitrocellulose membrane (Schleicher & Schuell) by
electroblotting. The membrane was blocked in 5% non-fat dry milk
tris-buffered saline with Tween (10 mM Tris (pH 8.0), 150 mM NaCl,
0.05% Tween 20) at room temperature for 1 hour. Anti-IRF-1, -IRF-2,
and anti-RB (Santa Cruz Biotechnology) were diluted 1:1,000 in 5%
non-fat dry milk tris-buffered saline with Tween. The membrane was
incubated with antibody at room temperature for 1 hour, washed
3 10 minutes with tris-buffered saline with Tween, and incubated
with the corresponding horseradish peroxidase-conjugated second-
ary antibody in 5% non-fat dry milk tris-buffered saline with Tween
at room temperature for 1 hour then washed with tris-buffered saline
with Tween. Bands were visualized with an enhanced chemilumi-
nescence Western detection system (Amersham Biosciences). After
autoradiography, quantitation of the band intensity was performed
by densitometry analysis.
Electrophoresis mobility shift assay
Nuclear extracts were made from primary mouse keratinocytes, and
electrophoresis mobility shift as performed, as described previously
(Andrews and Faller, 1991). A double-stranded oligonucleotide
corresponding to the 27 to 8 site of the mC1rA promoter was
end-labeled with [g-32P]ATP using T4 polynucleotide kinase
(Invitrogen) and purified with a Microspin column (Amersham
Biosciences). Supershift assays were performed as described
previously (Kim et al., 2000) with a slight modification: nuclear
extracts were preincubated with 2mg of anti-IRF-1, -IRF-2 or -IFN
consensus sequence binding protein antibodies (Santa Cruz Bio-
technology) for 1 hour on ice before addition of the labeled probe.
Protein–DNA complexes were resolved by electrophoresis on a 5%
non-denaturing polyacrylamide gel, and subsequently dried, and
exposed to X-ray film.
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